Skip Navigation

Study Suggests Coenzyme Q10 Slows Functional Decline in Parkinson's Disease

Internet URL

http://www.ninds.nih.gov/news_and_events/press_releases/pressrelease_parkinsons_coenzymeq10_101402.htm  

Sponsoring Agency

National Institute of Neurological Disorders and Stroke, National Institutes of Health

Description

Results of the first placebo-controlled, multicenter clinical trial of the compound coenzyme Q10 suggest that it can slow disease progression in patients with early-stage Parkinson's disease (PD).

Related Topics

Review Date

4/25/2007